NPM1 and leukemia: In this specific patient, the emergence of a cellular immune response to wt-NPM1 was not accompanied by side effects, such as GVHD or BM aplasia, and coincided with leukemia control, further suggesting the potential role and relative safety of NPM1-directed immunity after HSCT.